Alpha

Type to search peptides...

Research

Scientific articles on peptide research, documentation, purity, and traceability.

101 Articles5 Courses41 Peptides

Alpha Research

Longevity

Assay matrix
LongevityScientific
LongevityScientific

Telomere Dynamics and Peptide Research: Epitalon, TERT Activation, and Telomerase-Directed Approaches

Review of telomere structure, the terminal replication problem, Epitalon's TERT activation mechanism (H3K9me3/H3K4me3 histone changes at the TERT promoter, TRAP assay, in vitro replicative lifespan extension), and telomeric heterochromatin maintenance via the SIRT6/NAD+ axis.

January 12, 20264 min

Alpha Research

Longevity

Molecule panel
LongevityScientific
LongevityScientific

GABAergic and Serotonergic Modulation by Neuropeptides: Selank, Semax, and DSIP in Preclinical Anxiety Models

Selank indirectly modulates GABA-A through enkephalin aminopeptidase inhibition, Semax activates serotonergic turnover secondary to BDNF/TrkB, and DSIP modulates NMDAR and the HPA axis in preclinical anxiety models with EPM, Vogel, and SIH-specific parameters.

January 11, 20263 min

Alpha Research

Longevity

Pathway map
LongevityScientific
LongevityScientific

Neuropeptide Neurotransmission: Synthesis, Release, Receptor Specificity, and Research Differentiation from Classical Neurotransmitters

Neuropeptides are distinguished from classical neurotransmitters by dense-core vesicle synthesis, high-frequency release requirements, volume transmission, and exclusively GPCR signaling. Analysis of POMC processing, Y1R/Y2R/MC4R receptors, and research parameters.

January 9, 20263 min

Alpha Research

Longevity

Protocol sheet
LongevityEducational
LongevityEducational

Mitochondrial NAD+ Pools, Complex I Function, and Peptide Research Targeting the NAMPT/NMNAT Axis

Mitochondrial NAD+ pools are regulated by NMNAT3, distinct from cytoplasmic pools. Complex I requires NAD+ as hydride acceptor; its aging dysfunction links to NAMPT decline and PARP-1/CD38 substrate competition.

January 7, 20263 min

Alpha Research

Longevity

Evidence grid
LongevityTrends
LongevityTrends

Longevity-Associated Peptides in 2026 Research: Telomerase Activation, Senolytic Mechanisms, and NAD+ Biology

Review of peptides with preclinical evidence across multiple aging pathways: Epitalon and TERT activation, SS-31 and mitochondrial preservation, BPC-157 and senescence reduction, and the role of NAD+ in SIRT6-mediated telomeric maintenance.

January 5, 20263 min

Alpha Research

Longevity

Protocol sheet
LongevityEducational
LongevityEducational

Peptides in Cognitive Research: BDNF/TrkB Signaling, Neuroplasticity Markers, and Preclinical Nootropic Data

Review of how peptides including Selank, Semax, BPC-157, and GHK-Cu modulate BDNF/TrkB signaling, induce neuroplasticity markers (Arc, synapsin-1, GluA1), and perform in preclinical memory models including MWM, NOR, and passive avoidance.

January 3, 20263 min

Alpha Research

Longevity

Pathway map
LongevityComparison
LongevityComparison

Selank vs Semax: Comparative Neuropeptide Profiles, Receptor Targets, and Cognitive Research Differentiation

Selank modulates GABA-A and induces BDNF; Semax activates ACTH/melanocortin pathways with effects on BDNF, dopamine, and hippocampal plasticity. Mechanistic comparison, anxiety vs cognition research models, and experimental parameters.

January 2, 20263 min

Alpha Research

Longevity

Evidence grid
LongevityComparison
LongevityComparison

NAD+ Precursor Pharmacokinetics: Comparative Bioavailability of NR, NMN, and Direct NAD+ Formulations

NR enters cells via ENT1/2 and is phosphorylated to NMN intracellularly; NMN is transported via Slc12a8; direct NAD+ requires extracellular degradation. Comparative analysis of tissue kinetics, brain penetration, and research endpoints.

December 31, 20254 min

Alpha Research

Longevity

Pathway map
LongevityScientific
LongevityScientific

NAD+ Decline and Cellular Senescence: Hallmarks of Aging, Sirtuin Deacylation, and PARP-1/CD38 NAD+ Consumption Dynamics

NAD+ decline during aging is driven by hyperactivated PARP-1 (DNA damage repair), inflammatory CD38 overexpression, and NAMPT reduction, with consequences on SIRT1-7 activity that accelerate cellular aging hallmarks.

December 29, 20254 min

Alpha Research

Longevity

Molecule panel
LongevityGuide
LongevityGuide

Bremelanotide (PT-141): MC3R/MC4R Agonism, Dopaminergic Pathway Activation, and Central Arousal Research Models

Bremelanotide is a melanocortin agonist with preferential selectivity for MC3R and MC4R that activates mesolimbic dopaminergic circuits in the medial preoptic area and hypothalamus, with preclinical data in central arousal models without direct peripheral action.

December 27, 20253 min

Alpha Research

Longevity

Evidence grid
LongevityGuide
LongevityGuide

Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro): GABA-A Modulation, BDNF Upregulation, and Anxiolytic Mechanism Research

Selank is a synthetic heptapeptide derived from tuftsin that modulates the GABA-A receptor, induces BDNF upregulation via TrkB, and demonstrates anxiolytic effects without sedation in rodent preclinical models with a profile distinct from benzodiazepines.

December 25, 20254 min

Alpha Research

Longevity

Pathway map
LongevityGuide
LongevityGuide

NAD+ (Nicotinamide Adenine Dinucleotide): Biosynthesis Pathways, CD38 Consumption, SIRT1-7 Activation, and Research Formulations

Review of the three NAD+ biosynthesis pathways (Preiss-Handler, Kynurenine, Salvage), CD38 as principal NAD+ consumer, and how NAD+ availability modulates SIRT1-7 sirtuins in preclinical aging and metabolic research models.

December 24, 20254 min